Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

INSTITUT PASTEUR

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Established: 1887-01-01

Employees: 1K

Market Cap: -

Website: http://www.pasteur.fr/en

Clinical Trials

Virological and Immunological Determinants of Arbovirus Infection in New Caledonia

Not Applicable

Recruiting

Conditions: Dengue
Zika
Arbovirus Infections
Chikungunya

Interventions: Other: Blood sample collection

First Posted Date: 2020-11-06

Last Posted Date: 2024-05-23

Lead Sponsor: Institut Pasteur

Target Recruit Count: 250

Registration Number: NCT04619823

Locations: 🇳🇨
Centre Hospitalier Territorial de Nouvelle-Calédonie, Dumbéa Sur Mer, New Caledonia

Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia

Recruiting

Conditions: Arbovirus Infections
Dengue
Zika
Chikungunya

First Posted Date: 2020-11-04

Last Posted Date: 2024-05-23

Lead Sponsor: Institut Pasteur

Target Recruit Count: 600

Registration Number: NCT04615364

Locations: 🇫🇷
Centre Hospitalier Territorial, Dumbéa Sur Mer, Nouvelle-Calédonie, France

Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2 Responsible for COVID-19

Completed

Conditions: Covid19

Interventions: Other: Questionnaires
Other: Phone interviews

First Posted Date: 2020-10-29

Last Posted Date: 2023-04-06

Lead Sponsor: Institut Pasteur

Target Recruit Count: 766818

Registration Number: NCT04607941

Locations: 🇫🇷
Caisse Nationale d'Assurance Maladie, Paris, France
🇫🇷
IPSOS, Paris, France

A Study to Investigate the Safety and Immunogenicity of the SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine Against Shigella Flexneri 2a

Phase 2

Completed

Conditions: Healthy

Interventions: Biological: Injection Placebo
Biological: Injection SF2A-TT15 10 µg Adjuvanted
Biological: Injection SF2A-TT15 2 µg Adjuvanted
Biological: Injection Adjuvanted Placebo
Biological: Injection SF2A-TT15 2 µg
Biological: Injection SF2A-TT15 10 µg

First Posted Date: 2020-10-26

Last Posted Date: 2024-04-23

Lead Sponsor: Institut Pasteur

Target Recruit Count: 248

Registration Number: NCT04602975

Locations: 🇰🇪
KEMRI / Henry M. Jackson Foundation Medical Research International, Kericho, Kenya

Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine

Phase 1

Completed

Conditions: COVID-19

Interventions: Biological: Two COVID-19 vaccine candidate (TMV-083/V-591) administrations - High dose
Biological: Two COVID-19 vaccine candidate (TMV-083/V-591) administrations - Low dose
Biological: One COVID-19 vaccine candidate (TMV-083/V-591) administration - High dose
Other: Placebo

First Posted Date: 2020-08-04

Last Posted Date: 2022-02-18

Lead Sponsor: Institut Pasteur

Target Recruit Count: 90

Registration Number: NCT04497298

Locations: 🇧🇪
SGS Life Sciences, Clinical Pharmacology Unit, Antwerp, Belgium
🇫🇷
CIC Cochin - Pasteur, Paris, France

COVID-19 Seroprevalence Study in French Guiana

Not Applicable

Completed

Conditions: Severe Acute Respiratory Syndrome
Covid19
Coronavirus Infection
SARS-CoV Infection

Interventions: Procedure: Blood sample

First Posted Date: 2020-07-29

Last Posted Date: 2022-02-15

Lead Sponsor: Institut Pasteur

Target Recruit Count: 3541

Registration Number: NCT04490850

Locations: 🇬🇫
Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana
🇬🇫
Laboratoire de biologie méicale, Institut Pasteur de la Guyane, Cayenne, French Guiana
🇬🇫
Laboratoires Eurofins Guyane, Cayenne, French Guiana

and more 2 locations

Study of the Pathogenesis of Olfactory Disorders in COVID-19

Completed

Conditions: Sars-CoV2
Severe Acute Respiratory Syndrome
Coronavirus Infection

Interventions: Other: Nasal swab
Other: Taste and olfactory function evaluation

First Posted Date: 2020-04-29

Last Posted Date: 2021-01-29

Lead Sponsor: Institut Pasteur

Target Recruit Count: 26

Registration Number: NCT04366934

Locations: 🇫🇷
Hôpital Lariboisière, Policlinique, Paris, France
🇫🇷
Hôpital Lariboisière, Service ORL, Paris, France

Household Transmission Investigation Study for COVID-19 in Tropical Regions

Not Applicable

Completed

Conditions: Coronavirus Infections
Severe Acute Respiratory Syndrome
SARS-CoV Infection

Interventions: Procedure: Human biological samples

First Posted Date: 2020-03-31

Last Posted Date: 2022-02-15

Lead Sponsor: Institut Pasteur

Target Recruit Count: 245

Registration Number: NCT04328129

Locations: 🇬🇫
Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana
🇬🇫
Institut Pasteur de la Guyane, Cayenne, French Guiana
🇬🇵
Institut Pasteur de Guadeloupe, Les Abymes, Guadeloupe

and more 1 locations

Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France

Completed

Conditions: COVID-19
SARS (Severe Acute Respiratory Syndrome)

Interventions: Other: Human Biological samples

First Posted Date: 2020-03-27

Last Posted Date: 2023-07-07

Lead Sponsor: Institut Pasteur

Target Recruit Count: 5000

Registration Number: NCT04325646

Locations: 🇫🇷
CHU Amiens-Picardie, Amiens, France
🇫🇷
EHPAD Villa Concorde, Asnieres sur seine, France
🇫🇷
CHU François Mitterand, Dijon, France

and more 18 locations

Role of Nasal Dysbiosis in Parkinson Disease

Recruiting

Conditions: Parkinson Disease

Interventions: Other: Nasal Swab

First Posted Date: 2020-01-30

Last Posted Date: 2023-10-02

Lead Sponsor: Institut Pasteur

Target Recruit Count: 320

Registration Number: NCT04249245

Locations: 🇫🇷
Pitie-Salpetriere Hospital, Paris, France
🇬🇵
Centre Hospitalier Universitaire, Pointe-à-Pitre, Guadeloupe

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy